16 results
8-K
NBSE
NeuBase Therapeutics Inc
17 Jan 24
Departure of Directors or Certain Officers
6:15am
in his role as the Company’s Chief Financial Officer during his tenure as the Company’s interim Chief Executive Officer. Dr. Stephan is expected
8-K
EX-3.1
NBSE
NeuBase Therapeutics Inc
23 Sep 19
Amendments to Articles of Incorporation or Bylaws
5:09pm
ARTICLE V OFFICERS
Section 30.
Officers Designated
Section 31.
Tenure and Duties of Officers
Section 32.
Delegation of Authority
Section 33 … thereof to which the Board of Directors has delegated such responsibility.
Section 31. Tenure and Duties of Officers.
General. All officers shall hold
DEF 14A
nq0 loqinzhs6p51
7 Mar 14
Definitive proxy
12:00am
8-K
qgyy31d
23 May 13
Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
12:00am
8-K
EX-99.1
yh41o0q4uuvfekdj
23 May 13
Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
12:00am
8-K
EX-10.2
8jyjuljt0
5 Apr 07
Completion of Acquisition or Disposition of Assets
12:00am
8-K
8uej8spfsaucwelmi4yj
5 Apr 07
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-10.3
aco0ci d0
5 Apr 07
Completion of Acquisition or Disposition of Assets
12:00am
SC 14F1
zqh fj50ldx
8 Mar 07
Statement regarding change in majority of directors
12:00am
- Prev
- 1
- Next